CHCs are adopting AI-powered clinical decision support tools to improve patient care, but concerns over accuracy, bias, and oversight call for stronger governance.
CHCs are adopting AI-powered clinical decision support tools to improve patient care, but concerns over accuracy, bias, and oversight call for stronger governance.
The ABA and IIF, among others, generally support the non-prescriptive approach.
New course aims to help SMEs remain compliant in a complex regulatory landscape.
The regulator’s Supercharged Sandbox is a secure, controlled environment where firms can experiment with advanced AI technologies without worrying about compliance breaches.
Firms should expect the Review’s analysis to inform supervisory priorities, perimeter policy and future guidance across a range of areas, with the FCA continuing its plans to regulate for growth.
The new report breaks down recommendations from over 100 experts, offering emerging policy priorities around frontier AI oversight.
The Action Plan does not create new legal obligations but sets out steps for operationalizing the AI Act, NIS2, DORA, and the Cyber Resilience Act.
No new rules; the FCA’s approach is to double down on the existing outcomes-based approach, with Consumer Duty, SMCR, and operational resilience frameworks remaining at the forefront.